Literature DB >> 693578

Sensory dysfunction in children who toe walk.

P Montgomery, J Gauger.   

Abstract

In order to formulate a hypothesis regarding the etiology of toe walking, the sensory processing abilities of 17 mentally retarded children who toe walk were examined. A galvanic skin response was used to compare reactions of the mentally retarded children and a group of normal children to a variety of sensory stimuli. Galvanic skin response testing did not reveal significant differences between the two groups in processing sensory input. Scores of the mentally retarded children from a postrotary nystagmus test were compared to values for normal children of the same age, and the results indicated that vestibular dysfunction was present in all of the subjects. We hypothesize that children may toe walk to increase somatosensory input to the lateral vestibular nucleus (Deiter's) and the lateral vestibulospinal tract to facilitate support tone in the lower extremities during walking.

Entities:  

Mesh:

Year:  1978        PMID: 693578     DOI: 10.1093/ptj/58.10.1195

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  4 in total

1.  McArdle's disease: A differential diagnosis of idiopathic toe walking.

Authors:  David Pomarino; Stephan Martin; Andrea Pomarino; Stefanie Morigeau; Saskia Biskup
Journal:  J Orthop       Date:  2018-05-08

2.  Does botulinum toxin A improve the walking pattern in children with idiopathic toe-walking?

Authors:  Pähr Engström; Elena M Gutierrez-Farewik; Asa Bartonek; Kristina Tedroff; Christina Orefelt; Yvonne Haglund-Åkerlind
Journal:  J Child Orthop       Date:  2010-05-12       Impact factor: 1.548

3.  Idiopathic toe walking and sensory processing dysfunction.

Authors:  Cylie M Williams; Paul Tinley; Michael Curtin
Journal:  J Foot Ankle Res       Date:  2010-08-16       Impact factor: 2.303

4.  Vestibular Hair Cells Require CAMSAP3, a Microtubule Minus-End Regulator, for Formation of Normal Kinocilia.

Authors:  Josephine O'Donnell; Jing Zheng
Journal:  Front Cell Neurosci       Date:  2022-06-17       Impact factor: 6.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.